Product photoPhoto byFDA press release
Bionpharma Inc. has issued a voluntary nationwide recall of a single batch (2310083) of a pneumonia treatment, Atovaquone Oral Suspension, 750 mg/mL, due to bacterial contamination. The affected product was manufactured by CoreRx, Inc. in Clearwater, Florida, and distributed across the United States between December 2023 and June 2024.…